1. World Health Organization. (2015) African regulators’ meeting looking to expedite approval of vaccines and therapies for Ebola, http://www.who.int/medicines/news/AFR_reg_meet/en/ , accessed 6 August 2015.
2. Duggal, E., Kashyap, P., Singh, R. and Kakar, S. (2014) Fast track approaches for drug approval across the globe. Asian Pacific Journal of Health Science 1(1): 2–12.
3. Liberti, L., Stolk, P., McAuslane, N., Somauroo, A., Breckenridge, A.M. and Leufkens, H. (2015) Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions. Clinical Pharmacology and Therapeutics 98(5): 477–9.
4. Drugs for Neglected Diseases Initiative. (2013) DNDi: An innovative approach to R&D for neglected patients ten years of experience & lessons learned by DNDi, http://www.dndi.org/images/stories/pdf_aboutDNDi/DNDiModel/DNDi_Modelpaper_2013.pdf , accessed 6 August 2015.
5. The Global Fund. (2010) Global fund quality assurance policy for pharmaceutical products (as amended and restated on 14 December 2010), http://www.theglobalfund.org/documents/psm/PSM_QAPharm_Policy_en/ , accessed 6 August 2015.